Cargando…
Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation
[Image: see text] The creation of discrete, covalent bonds between a protein and a functional molecule like a drug, fluorophore, or radiolabeled complex is essential for making state-of-the-art tools that find applications in basic science and clinical medicine. Photochemistry offers a unique set of...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970001/ https://www.ncbi.nlm.nih.gov/pubmed/35373206 http://dx.doi.org/10.1021/jacsau.1c00530 |
_version_ | 1784679372770246656 |
---|---|
author | Earley, Daniel F. Guillou, Amaury Klingler, Simon Fay, Rachael Gut, Melanie d’Orchymont, Faustine Behmaneshfar, Shamisa Reichert, Linus Holland, Jason P. |
author_facet | Earley, Daniel F. Guillou, Amaury Klingler, Simon Fay, Rachael Gut, Melanie d’Orchymont, Faustine Behmaneshfar, Shamisa Reichert, Linus Holland, Jason P. |
author_sort | Earley, Daniel F. |
collection | PubMed |
description | [Image: see text] The creation of discrete, covalent bonds between a protein and a functional molecule like a drug, fluorophore, or radiolabeled complex is essential for making state-of-the-art tools that find applications in basic science and clinical medicine. Photochemistry offers a unique set of reactive groups that hold potential for the synthesis of protein conjugates. Previous studies have demonstrated that photoactivatable desferrioxamine B (DFO) derivatives featuring a para-substituted aryl azide (ArN(3)) can be used to produce viable zirconium-89-radiolabeled monoclonal antibodies ((89)Zr-mAbs) for applications in noninvasive diagnostic positron emission tomography (PET) imaging of cancers. Here, we report on the synthesis, (89)Zr-radiochemistry, and light-triggered photoradiosynthesis of (89)Zr-labeled human serum albumin (HSA) using a series of 14 different photoactivatable DFO derivatives. The photoactive groups explore a range of substituted, and isomeric ArN(3) reagents, as well as derivatives of benzophenone, a para-substituted trifluoromethyl phenyl diazirine, and a tetrazole species. For the compounds studied, efficient photochemical activation occurs inside the UVA-to-visible region of the electromagnetic spectrum (∼365–450 nm) and the photochemical reactions with HSA in water were complete within 15 min under ambient conditions. Under standardized experimental conditions, photoradiosynthesis with compounds 1–14 produced the corresponding (89)ZrDFO-PEG(3)-HSA conjugates with decay-corrected isolated radiochemical yields between 18.1 ± 1.8% and 62.3 ± 3.6%. Extensive density functional theory (DFT) calculations were used to explore the reaction mechanisms and chemoselectivity of the light-induced bimolecular conjugation of compounds 1–14 to protein. The photoactivatable DFO-derivatives operate by at least five distinct mechanisms, each producing a different type of bioconjugate bond. Overall, the experimental and computational work presented here confirms that photochemistry is a viable option for making diverse, functionalized protein conjugates. |
format | Online Article Text |
id | pubmed-8970001 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-89700012022-04-01 Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation Earley, Daniel F. Guillou, Amaury Klingler, Simon Fay, Rachael Gut, Melanie d’Orchymont, Faustine Behmaneshfar, Shamisa Reichert, Linus Holland, Jason P. JACS Au [Image: see text] The creation of discrete, covalent bonds between a protein and a functional molecule like a drug, fluorophore, or radiolabeled complex is essential for making state-of-the-art tools that find applications in basic science and clinical medicine. Photochemistry offers a unique set of reactive groups that hold potential for the synthesis of protein conjugates. Previous studies have demonstrated that photoactivatable desferrioxamine B (DFO) derivatives featuring a para-substituted aryl azide (ArN(3)) can be used to produce viable zirconium-89-radiolabeled monoclonal antibodies ((89)Zr-mAbs) for applications in noninvasive diagnostic positron emission tomography (PET) imaging of cancers. Here, we report on the synthesis, (89)Zr-radiochemistry, and light-triggered photoradiosynthesis of (89)Zr-labeled human serum albumin (HSA) using a series of 14 different photoactivatable DFO derivatives. The photoactive groups explore a range of substituted, and isomeric ArN(3) reagents, as well as derivatives of benzophenone, a para-substituted trifluoromethyl phenyl diazirine, and a tetrazole species. For the compounds studied, efficient photochemical activation occurs inside the UVA-to-visible region of the electromagnetic spectrum (∼365–450 nm) and the photochemical reactions with HSA in water were complete within 15 min under ambient conditions. Under standardized experimental conditions, photoradiosynthesis with compounds 1–14 produced the corresponding (89)ZrDFO-PEG(3)-HSA conjugates with decay-corrected isolated radiochemical yields between 18.1 ± 1.8% and 62.3 ± 3.6%. Extensive density functional theory (DFT) calculations were used to explore the reaction mechanisms and chemoselectivity of the light-induced bimolecular conjugation of compounds 1–14 to protein. The photoactivatable DFO-derivatives operate by at least five distinct mechanisms, each producing a different type of bioconjugate bond. Overall, the experimental and computational work presented here confirms that photochemistry is a viable option for making diverse, functionalized protein conjugates. American Chemical Society 2022-02-08 /pmc/articles/PMC8970001/ /pubmed/35373206 http://dx.doi.org/10.1021/jacsau.1c00530 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Earley, Daniel F. Guillou, Amaury Klingler, Simon Fay, Rachael Gut, Melanie d’Orchymont, Faustine Behmaneshfar, Shamisa Reichert, Linus Holland, Jason P. Charting the Chemical and Mechanistic Scope of Light-Triggered Protein Ligation |
title | Charting the Chemical and Mechanistic Scope of Light-Triggered
Protein Ligation |
title_full | Charting the Chemical and Mechanistic Scope of Light-Triggered
Protein Ligation |
title_fullStr | Charting the Chemical and Mechanistic Scope of Light-Triggered
Protein Ligation |
title_full_unstemmed | Charting the Chemical and Mechanistic Scope of Light-Triggered
Protein Ligation |
title_short | Charting the Chemical and Mechanistic Scope of Light-Triggered
Protein Ligation |
title_sort | charting the chemical and mechanistic scope of light-triggered
protein ligation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8970001/ https://www.ncbi.nlm.nih.gov/pubmed/35373206 http://dx.doi.org/10.1021/jacsau.1c00530 |
work_keys_str_mv | AT earleydanielf chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT guillouamaury chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT klinglersimon chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT fayrachael chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT gutmelanie chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT dorchymontfaustine chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT behmaneshfarshamisa chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT reichertlinus chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation AT hollandjasonp chartingthechemicalandmechanisticscopeoflighttriggeredproteinligation |